Aldosterone in heart failure: Pathophysiology and treatment
- 1 December 2004
- journal article
- research article
- Published by Springer Nature in Current Heart Failure Reports
- Vol. 1 (4) , 171-175
Abstract
Aldosterone produces adverse effects on the vasculature (endothelial dysfunction) and on the myocardium (myocardial fibrosis). These effects have adverse clinical consequences that result in increases in deaths caused by sudden death and by progressive heart failure. The Randomized Aldactone Evaluation Study and the Eplerenone Post-acute Myocardial Infarction Heart Failure Efficacy and Survival Study show this clearly. Aldosterone blockade should become a regular third neuroendocrine-blocking drug in patients with chronic heart failure.Keywords
This publication has 9 references indexed in Scilit:
- Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular HypertrophyCirculation, 2003
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 2003
- Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertensionAmerican Journal of Hypertension, 2002
- Spironolactone Increases Nitric Oxide Bioactivity, Improves Endothelial Vasodilator Dysfunction, and Suppresses Vascular Angiotensin I/Angiotensin II Conversion in Patients With Chronic Heart FailureCirculation, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive RatsHypertension, 1998
- Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patientsCardiovascular Research, 1997
- Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1995
- Reactive and reparative myocardial fibrosis in arterial hypertension in the ratCardiovascular Research, 1992